These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 9270472

  • 1. Unexpected findings of study of selegiline have not been treated with caution its authors advised.
    Silva MT, Schapira AH, Jenner P.
    BMJ; 1997 Aug 09; 315(7104):370. PubMed ID: 9270472
    [No Abstract] [Full Text] [Related]

  • 2. [Levodopa+selegiline combination and increase of risk of mortality in the treatment of Parkinson disease].
    Dubois B, Montastruc JL.
    Rev Neurol (Paris); 1996 Feb 09; 152(2):103-5. PubMed ID: 8761616
    [No Abstract] [Full Text] [Related]

  • 3. Selegiline and excess mortality.
    Oakes D.
    Clin Neuropharmacol; 1997 Dec 09; 20(6):542. PubMed ID: 9403228
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Selegeline is effective and safe in early stages.
    MacMahon DG, Bland R.
    BMJ; 1996 Mar 16; 312(7032):703; author reply 704-5. PubMed ID: 8597748
    [No Abstract] [Full Text] [Related]

  • 8. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.
    Gerlach M, Riederer P, Vogt H.
    BMJ; 1996 Mar 16; 312(7032):704; author reply 704-5. PubMed ID: 8597750
    [No Abstract] [Full Text] [Related]

  • 9. Deprenyl's neuroprotective action remains unresolved.
    van Hilten JJ, Bloem BR, Klaassen AA.
    Ann Neurol; 1996 Aug 16; 40(2):266-7. PubMed ID: 8773615
    [No Abstract] [Full Text] [Related]

  • 10. [Revision of the treatment strategy in Parkinson disease].
    Staal-Schreinemachers AL, Wesseling H, Lakke JP.
    Ned Tijdschr Geneeskd; 1986 May 17; 130(20):914-8. PubMed ID: 3724865
    [No Abstract] [Full Text] [Related]

  • 11. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug 17; 11(60):108-11. PubMed ID: 12199263
    [Abstract] [Full Text] [Related]

  • 12. Selegiline slows the progression of the symptoms of Parkinson disease.
    Pålhagen S, Heinonen E, Hägglund J, Kaugesaar T, Mäki-Ikola O, Palm R, Swedish Parkinson Study Group.
    Neurology; 2006 Apr 25; 66(8):1200-6. PubMed ID: 16540603
    [Abstract] [Full Text] [Related]

  • 13. Selegiline and mortality in subjects with Parkinson's disease: a longitudinal community study.
    Van Gerpen JA, Ahlskog JE.
    Neurology; 2001 Jul 24; 57(2):368-9; author reply 369-70. PubMed ID: 11468339
    [No Abstract] [Full Text] [Related]

  • 14. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Causes of death need confirmation.
    Jellinger KA.
    BMJ; 1996 Mar 16; 312(7032):704-5. PubMed ID: 8597751
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) (author's transl)].
    Eisenlohr JJ, Gehlen W.
    MMW Munch Med Wochenschr; 1974 Jul 12; 116(28):1353-6. PubMed ID: 4212699
    [No Abstract] [Full Text] [Related]

  • 19. Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Stopping selegeline may lead to problems for patients.
    Anderson KE, Girdwood AC, Wilson JA.
    BMJ; 1996 Mar 16; 312(7032):702; author reply 704-5. PubMed ID: 8597745
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of parkinsonism].
    Houeland T, Slettnes O, Sjaastad O.
    Tidsskr Nor Laegeforen; 1977 Jan 10; 97(1):6-9. PubMed ID: 847669
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.